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Background: Aspegillus is an important pathogen in patients with impaired host defences. These 
mycelial fungi can cause local as well disseminated disease. Two forms of pulmonary aspergillosis 
are frequently seen : 1. pulmonary or brochial aspergilloma (fungus ball) due to secondary 
invasion of a a tuberculous cavity  and 2. allergic bronchopulmonary aspergilosis. The aim study 
was to evaluate the outcome of surgical management in patients with Aspergillomas of the lung 
with recurrent and severe Haemoptysis. 
Methods: Eight patients were treated surgically for Aspergillomas of the lung; six of them in 
Maputo Central Hospital and the other two in Medina Hospital in Somalia. These Aspergillums 
lesions were located in the upper lobe as a fungal ball. In five of the patients the lesions were 
located in the right upper lobe while in the other three the left upper lobe was involved. In Maputo 
Central Hospital, investigations done in all six patients included the plain chest X-rays, CT scans, 
bronchoscopy and common laboratory exams. The two patients in Medina Hospital had only plain 
X-rays and common laboratory exams. All the eight patients had upper lobectomy. No 
intrathoracic contamination occurred during surgery. 
Results: Eight patients with recurrent and severe Haemoptysis had surgical treatment (upper 
lobectomies) without intrathoracic contamination. All the patients had an average of ten days of 
postoperative hospital. 
Complications: One patient has died for postoperative haemorrhage among those patients treated 
in Maputo Central Hospital. 
Conclusion: Our limited experience of 8 patients showed that surgical treatment is effective and 




Aspergilloma is the most common and best-
recognized form of pulmonary involvement by 
Aspergillus The aspergilloma (fungal ball) 
consists of masses of fungal mycelia, 
inflammatory cells, fibrin, mucus and tissue 
debris, usually developing in a preformed lung 
cavity. Although other fungi may cause the 
formation of the fungal ball such as  
Zygomycetes and Fusarium. Aspergillus spp 
(specifically, A. fumigatus) are by far the most 
common etiologic agents. 
 
Patients and Methods 
 
The cases studied included eight patients who 
had been treated surgically for Aspergillums of 
the lung; six of them in Maputo Central Hospital 
and the remaining two  in Medina Hospital. Of 
the 8 patients 2 were female and 6 were male, 
aged between 22 – 38 years old, mean age is 30 
years old. The most complained of symptoms 
with massive Haemoptysis and a dyspnoea. The 
six patients from Maputo Central Hospital 
among them the two females were referred by 
the pneumology ward of the same hospital and 
all had a history of treatment for tuberculosis. 
The six patients had all possible investigations 
including chest X-rays, CT-scan, bronchoscopy 
and the required common laboratory tests. Chest 
radiographs showed cavities with fungal balls in 
the upper lobes.  
 
The 2 patients from Medina Hospital had only 
plain chest X-rays which confirmed the 
presence of apical cavities with fungal balls. 
The cavities were located: in the right upper 





All eight patients with recurrent and severe 
haemoptysis had upper lobectomy. During 
surgery, adhesions of the upper lobe to the chest 
wall were carefully removed. Single ligation and 
division of the hilar elements was performed 
avoiding intrapleural spillage and cavity 
contamination. Seven of the  patients stayed in 
the hospital for not more than 10 days and had 
fully recovered on discharge. They were able to 
return to normal routine activities. In these 
patients, the aspergilloma was confined to the 
apical lobes and therefore they were good 
candidates for surgery. One patients among 
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those treated in Maputo Central Hospital died of 




The true incidence of aspergilloma is unknown. 
In a study of 544 patients with pulmonary 
cavities secondary to tuberculosis, 11% had 
radiologic evidence of aspergilloma. The most 
common predisposing factor was the presence 
of a pre-existing lung cavity formed secondary 
to tuberculosis, sarcoidosis, bronchiectasis or 
bronchial cysts1. Of these, tuberculosis is the 
most frequently associated condition as 
observed in our cases.  
 
Occasionally aspergilloma might be described in 
cavities caused by other fungal infections. It is 
believed that inadequate drainage facilitates the 
growth of Aspergillus on the walls of these 
cavities. Usually, the fungus does not invade the 
surrounding lung parenchyma or blood vessels; 
exceptions, however, have been noted. The 
natural history of aspergilloma is variable. In the 
majority of cases, the lesion remains stable, 
however, in approximately 10% of cases it may 
decrease in size or resolve spontaneously 
without treatment. Rarely, the aspergilloma 
increases in size. 
 
An aspergilloma may exist for years without 
causing symptoms. Most patients will 
experience mild haemoptysis, but severe 
haemoptysis may occur, particularly in patients 
with underlying tuberculosis. Bleeding usually 
occurs from bronchial blood vessels lining the 
cavity, endotoxins released by the fungus with 
haemolytic properties, and mechanical friction 
of the aspergilloma with the cavity wall blood 
vessels. The cough and dyspnea are probably 
more related to the underlying lung disease. 
Fever is rare unless there is a secondary 
bacterial infection.   
Whenever massive and severe haemoptysis 
starts, there should be delay with a prolonged 
observation and conservative treatment in the 
cases where aspergilloma is resectable and the 
remaining lung has a good predictable function. 





1. Soubani: “The Clinical Spectrum of 
Pulmonary Aspergillosis” Chest, 
Volume 121(6). June 2002 
2. Roberts CM, Citron KM, Strickland B. 
Intrathoracic aspergilloma: role of CT in 
diagnosis and treatment. Radiology 
1987 165: 123-128 
3. Bandoh S, Fujita J, Fukunaga Y, et al. 
Cavitary lung cancer with an 
aspergilloma-like shadow. Lung Cancer 
1999; 26:195-198 
4. Le Thi HD, Wechsler B, Chamuzeau JP, 
et al. Pulmonary aspergilloma 
complicating Wegner’s granulomatosis 
[letter]. Scand J Rheumatol 1995; 
24:260  
5. McCarthy DS, Pepys J. Pulmonary 
aspergilloma: clinical immunology. Clin 
allergy 1973; 3:57-70 
6. Pennington JE. Aspergilloma lung 
disease. Med Clin North Am 1980; 
64:475-490 
7. Yamada H, Kohno S, Koga H, et al. 
Topical treatment of pulmonary 
aspergilloma by antifungals: 
relationship between duration of the 
disease and efficacy of therapy. Chest 
1993;  
     103:1421-1425. 
8. Munk PL, Vellet AD, Rankin RN et al. 
Interactivity aspergilloma: transthoracic 
percutaneous injection of amphotercin 
gelatine solution, Radiology 1993; 
188:821 – 823. 
